Arthroscopic partial meniscectomy has been considered a gold standard treatment for meniscal tears for the past three decades, which has led to partial meniscectomy being the most commonly performed orthopaedic procedure in countries across three continents. Because of the prevalence of meniscal tears, there is a tremendous impact of their ‘simple’ surgical management on the world’s population. The management of degenerative meniscal tears has been changing due to numerous level I studies. While the majority of these studies find little difference between conservative management and partial meniscectomy, these studies have multiple exclusions and high cross-over rates from the non-surgical to the surgical groups. We present a review of the evidence and consensus statements from multiple continents on the treatment of degenerative meniscal tears.
Contributors All authors have contributed to the writing, editing and conception of this manuscript.
Competing interests CDH—Musculoskeletal Transplant Foundation Medical Board of Trustees and ISAKOS Executive Committee and DAP—Executive Committee and Boards of ISAKOS and APKASS, Editorial Board of JISAKOS and OJSM, Consultancy Arthrex and Amplitude Orthopaedics, Institutional Support from Arthrex and Smith and Nephew, Shares in 360 Knee Systems.
Provenance and peer review Commissioned; externally peer reviewed